U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C9H16N6O2
Molecular Weight 240.2623
Optical Activity UNSPECIFIED
Defined Stereocenters 3 / 3
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of RONOPTERIN

SMILES

[H][C@@]1(CNC2=NC(N)=NC(N)=C2N1)[C@@H](O)[C@H](C)O

InChI

InChIKey=NDSDGUULXHNXGA-RPDRRWSUSA-N
InChI=1S/C9H16N6O2/c1-3(16)6(17)4-2-12-8-5(13-4)7(10)14-9(11)15-8/h3-4,6,13,16-17H,2H2,1H3,(H5,10,11,12,14,15)/t3-,4+,6-/m0/s1

HIDE SMILES / InChI

Molecular Formula C9H16N6O2
Molecular Weight 240.2623
Charge 0
Count
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 3 / 3
E/Z Centers 0
Optical Activity UNSPECIFIED

Vasopharm BIOTECH is developing 4-aminotetrahydrobiopterin (ronopterin, VAS 203), a nitric oxide synthase inhibitor, for the treatment of traumatic brain injury. Ronopterin is an allosteric nitric oxide (NO) synthase inhibitor interacting with the tetrahydrobiopterinbinding site of the enzyme. Pre-clinical, proof-of-principle studies using controlled cortical impact showed that VAS203 had significant and positive effects on elevated intracranial pressure (ICP), which contributes to the deleterious consequences of TBI, as well as on neurological outcome measured with behavioural tests. By targeting both cerebral blood vessels and cerebral tissue in a region-specific manner VAS203 represents a completely novel pharmacological approach to TBI that can be administrated in addition to best standard of care. Ronopterin is currently in development for the treatment of traumatic brain injury.In the phase III clinical trial, ronopterin is administered as a 17 mg/kg intravenous infusion over 48 hours (daily dose of 8.5 mg/kg).

CNS Activity

Curator's Comment: VAS-203 passed the BBB both in healthy and traumatized mouse brain

Approval Year

PubMed

PubMed

TitleDatePubMed
A 4-amino analogue of tetrahydrobiopterin attenuates endotoxin-induced hemodynamic alterations and organ injury in rats.
2002 Aug
Effects of the nitric oxide synthase inhibitor ronopterin (VAS203) on renal function in healthy volunteers.
2019 May

Sample Use Guides

In the phase III clinical trial, ronopterin is administered as a 17 mg/kg intravenous infusion over 48 hours (daily dose of 8.5 mg/kg)
Route of Administration: Intravenous
Endothelium-dependent relaxations of pig pulmonary and coronary artery strips to bradykinin or calcium ionophore A23187 were inhibited by 4-aminotetrahydrobiopterin in a concentration-dependent manner. Half-maximal inhibition was observed at 60 - 65 uM (pulmonary artery) and 200 - 250 uM 4-aminotetrahydrobiopterin (coronary artery). Pig coronary artery strips precontracted with 0.1 uM 9, 11-dideoxy-9, 11-methanoepoxy-prosta-glandin F(2alpha) (U46619) showed a time-dependent relaxation (monitored for up to 18 h) upon incubation with 1 ug ml(-1) lipopolysaccharide (LPS). Addition of 10 uM 4-aminotetrahydrobiopterin 1 h after LPS led to a pronounced inhibition of the LPS-triggered relaxation. Incubation of pulmonary and coronary artery strips with 1 ug ml(-1) LPS attenuated contractile responses to norepinephrine (1 uM) and U46619 (0.1 uM). This hyporeactivity of the blood vessels to vasoconstrictor agents was inhibited by 4-aminotetrahydrobiopterin in a concentration-dependent manner [IC(50)=17.5+/-5.9 uM (pulmonary artery) and 20.7+/-3 uM (coronary artery)]. The effect of 0.1 mM 4-ABH(4) was antagonized by coincubation with 0.1 mM sepiapterin.
Substance Class Chemical
Created
by admin
on Sat Dec 16 10:24:58 GMT 2023
Edited
by admin
on Sat Dec 16 10:24:58 GMT 2023
Record UNII
1D1Z87AY23
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
RONOPTERIN
INN  
Official Name English
VAS203
Code English
(1R,2S)-1-((6R)-2,4-DIAMINO-5,6,7,8-TETRAHYDROPTERIDIN-6-YL)PROPANE-1,2-DIOL
Systematic Name English
RONOPTERIN, (6R)-
INN   WHO-DD  
INN  
Common Name English
ronopterin [INN]
Common Name English
1,2-PROPANEDIOL, 1-(2,4-DIAMINO-5,6,7,8-TETRAHYDRO-6-PTERIDINYL)-, (1R,2S)-
Systematic Name English
(6R)-2,4-DIAMINO-5,6,7,8-TETRAHYDRO-6-(-ERYTHRO-1,2-DIHYDROXYPROPYL)PTERIDINE
Systematic Name English
VAS-203
Code English
4-AMINOTETRAHYDROBIOPTERIN
Common Name English
Ronopterin [WHO-DD]
Common Name English
(1R,2S)-1-(2,4-DIAMINO-5,6,7,8-TETRAHYDRO-6-PTERIDINYL)-1,2-PROPANEDIOL
Systematic Name English
1,2-PROPANEDIOL, 1-(2,4-DIAMINO-1,5,6,7-TETRAHYDRO-6-PTERIDINYL)-, (1R,2S)-
Systematic Name English
Classification Tree Code System Code
NCI_THESAURUS C29574
Created by admin on Sat Dec 16 10:24:58 GMT 2023 , Edited by admin on Sat Dec 16 10:24:58 GMT 2023
Code System Code Type Description
PUBCHEM
5287516
Created by admin on Sat Dec 16 10:24:58 GMT 2023 , Edited by admin on Sat Dec 16 10:24:58 GMT 2023
PRIMARY
SMS_ID
100000171835
Created by admin on Sat Dec 16 10:24:58 GMT 2023 , Edited by admin on Sat Dec 16 10:24:58 GMT 2023
PRIMARY
CAS
185243-78-1
Created by admin on Sat Dec 16 10:24:58 GMT 2023 , Edited by admin on Sat Dec 16 10:24:58 GMT 2023
PRIMARY
NCI_THESAURUS
C152249
Created by admin on Sat Dec 16 10:24:58 GMT 2023 , Edited by admin on Sat Dec 16 10:24:58 GMT 2023
PRIMARY
FDA UNII
1D1Z87AY23
Created by admin on Sat Dec 16 10:24:58 GMT 2023 , Edited by admin on Sat Dec 16 10:24:58 GMT 2023
PRIMARY
PUBCHEM
9881244
Created by admin on Sat Dec 16 10:24:58 GMT 2023 , Edited by admin on Sat Dec 16 10:24:58 GMT 2023
NON-SPECIFIC STEREOCHEMISTRY
CAS
206885-38-3
Created by admin on Sat Dec 16 10:24:58 GMT 2023 , Edited by admin on Sat Dec 16 10:24:58 GMT 2023
NON-SPECIFIC STEREOCHEMISTRY
DRUG BANK
DB12575
Created by admin on Sat Dec 16 10:24:58 GMT 2023 , Edited by admin on Sat Dec 16 10:24:58 GMT 2023
PRIMARY
INN
10122
Created by admin on Sat Dec 16 10:24:58 GMT 2023 , Edited by admin on Sat Dec 16 10:24:58 GMT 2023
PRIMARY
Related Record Type Details
SALT/SOLVATE -> PARENT
TARGET -> INHIBITOR
Related Record Type Details
ACTIVE MOIETY